Key Highlights: Implications: Tecentriq’s 7‑minute under‑the‑skin version should help Roche deepen its lung cancer business in India by easing pressure on overcrowded infusion centers...
Key Highlights: Implications: Emcure grabs massive share in India’s exploding CKD/anemia market, challenging Sun Pharma/Jubilant while locking in transplant dominance through Roche&#...
